Disease and Specific Subtypes
Neuromics adds 5-10 new Primary Human and iPSC Derived Cells per month. Selection of the cells is based on expressed customer requirements. We include the manufacture of customized defined media, and coatings.
Top users include Abbvie, AstraZeneca, BMS, Janssen, Novartis, HIH, and Simcere Pharmaceuticals.
|
|